My NCBI | Sign In
RSS Settings
  • Search: Lundsgaard D[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 17

    1.

    Clinical and biological efficacy of recombinant human interleukin-21 in patients with stage IV malignant melanoma without prior treatment: a phase IIa trial.

    Davis ID, Brady B, Kefford RF, Millward M, Cebon J, Skrumsager BK, Mouritzen U, Hansen LT, Skak K, Lundsgaard D, Frederiksen KS, Kristjansen PE, McArthur G.

    Clin Cancer Res. 2009 Mar 15;15(6):2123-9. Epub 2009 Mar 10.PMID: 19276257 [PubMed - indexed for MEDLINE]Related articles

    2.

    Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin.

    Johansen C, Usher PA, Kjellerup RB, Lundsgaard D, Iversen L, Kragballe K.

    Br J Dermatol. 2009 Feb;160(2):319-24. Epub 2008 Oct 21.PMID: 19016708 [PubMed - indexed for MEDLINE]Related articles

    3.

    Immune activation in advanced cancer patients treated with recombinant IL-21: multianalyte profiling of serum proteins.

    Dodds MG, Frederiksen KS, Skak K, Hansen LT, Lundsgaard D, Thompson JA, Hughes SD.

    Cancer Immunol Immunother. 2009 Jun;58(6):843-54. Epub 2008 Oct 17.PMID: 18925392 [PubMed - indexed for MEDLINE]Related articles

    4.

    IL-21 induces in vivo immune activation of NK cells and CD8(+) T cells in patients with metastatic melanoma and renal cell carcinoma.

    Frederiksen KS, Lundsgaard D, Freeman JA, Hughes SD, Holm TL, Skrumsager BK, Petri A, Hansen LT, McArthur GA, Davis ID, Skak K.

    Cancer Immunol Immunother. 2008 Oct;57(10):1439-49. Epub 2008 Feb 20.PMID: 18286285 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Interleukin-21 activates human natural killer cells and modulates their surface receptor expression.

    Skak K, Frederiksen KS, Lundsgaard D.

    Immunology. 2008 Apr;123(4):575-83. Epub 2007 Nov 14.PMID: 18005035 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    PolyI:C induction of diabetes is controlled by Iddm4 in rats with a full regulatory T cell pool.

    Hornum L, Lundsgaard D, Markholst H.

    Ann N Y Acad Sci. 2007 Sep;1110:65-72.PMID: 17911421 [PubMed - indexed for MEDLINE]Related articles

    7.

    An open-label, two-arm, phase I trial of recombinant human interleukin-21 in patients with metastatic melanoma.

    Davis ID, Skrumsager BK, Cebon J, Nicholaou T, Barlow JW, Moller NP, Skak K, Lundsgaard D, Frederiksen KS, Thygesen P, McArthur GA.

    Clin Cancer Res. 2007 Jun 15;13(12):3630-6.PMID: 17575227 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Flow sorting from organ material by intracellular markers.

    Moerch U, Nielsen HS, Lundsgaard D, Oleksiewicz MB.

    Cytometry A. 2007 Jul;71(7):495-500.PMID: 17542026 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Inhibition of NKG2D receptor function by antibody therapy attenuates transfer-induced colitis in SCID mice.

    Kjellev S, Haase C, Lundsgaard D, Ursø B, Tornehave D, Markholst H.

    Eur J Immunol. 2007 May;37(5):1397-406.PMID: 17407193 [PubMed - indexed for MEDLINE]Related articles

    10.

    Characteristics of rat CD4(+)CD25(+) T cells and their ability to prevent not only diabetes but also insulitis in an adoptive transfer model in BB rats.

    Holm TL, Lundsgaard D, Markholst H.

    Scand J Immunol. 2006 Jul;64(1):17-29.PMID: 16784487 [PubMed - indexed for MEDLINE]Related articles

    11.

    Reconstitution of Scid mice with CD4+CD25- T cells leads to rapid colitis: an improved model for pharmacologic testing.

    Kjellev S, Lundsgaard D, Poulsen SS, Markholst H.

    Int Immunopharmacol. 2006 Aug;6(8):1341-54. Epub 2006 May 23.PMID: 16782548 [PubMed - indexed for MEDLINE]Related articles

    12.

    Reactivity of naive CD4+CD25- T cells against gut microflora in healthy mice.

    Gad M, Lundsgaard D, Kjellev S, Kristensen NN, Seremet T, Straten PT, Claesson MH.

    Int Immunol. 2006 May;18(5):817-25. Epub 2006 Mar 30.PMID: 16574668 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    In vivo control of diabetogenic T-cells by regulatory CD4+CD25+ T-cells expressing Foxp3.

    Lundsgaard D, Holm TL, Hornum L, Markholst H.

    Diabetes. 2005 Apr;54(4):1040-7.PMID: 15793242 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Improved beta-cell survival and reduced insulitis in a type 1 diabetic rat model after treatment with a beta-cell-selective K(ATP) channel opener.

    Skak K, Gotfredsen CF, Lundsgaard D, Hansen JB, Sturis J, Markholst H.

    Diabetes. 2004 Apr;53(4):1089-95.PMID: 15047626 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    A co-transfer system in young prediabetic BB rats: reactivated autoreactive T cells can be partly controlled.

    Lundsgaard D, Markholst H.

    J Autoimmun. 2003 Dec;21(4):325-38.PMID: 14624756 [PubMed - indexed for MEDLINE]Related articles

    16.

    An F344 rat congenic for BB/DP rat-derived diabetes susceptibility loci Iddm1 and Iddm2.

    Hornum L, Lundsgaard D, Markholst H.

    Mamm Genome. 2001 Nov;12(11):867-8. No abstract available. PMID: 11845290 [PubMed - indexed for MEDLINE]Related articles

    17.

    Restoration of strong grasp and lateral pinch in tetraplegia due to cervical spinal cord injury.

    House JH, Gwathmey FW, Lundsgaard DK.

    J Hand Surg Am. 1976 Sep;1(2):152-9.PMID: 1018080 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    2 free full-text articles in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity